Fortrea (Nasdaq: FTRE) stands as a prominent global provider of clinical development and patient access solutions for the life sciences sector. We collaborate with emerging and established biopharmaceutical, medical device, and diagnostic companies to propel healthcare innovation, expediting the delivery of transformative therapies to patients in need. Fortrea specializes in phase I-IV clinical trial management, clinical pharmacology, advanced technology-driven trial solutions, and post-approval services. Backed by over three decades of experience across 20 therapeutic areas, a commitment to scientific rigour, profound insights, and a robust investigator site network, Fortrea is dedicated to driving advancements in healthcare.
Our dynamic and diverse team, comprising approximately 19,000 individuals across more than 90 countries, is strategically positioned to provide targeted and adaptable solutions on a global scale.
